Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chatelain

Showing results (231-240 of 306) with videos related to

Pageof 31
Sort By:
Pediatrie|June 1, 1984
[Byler's disease. Ultrastructural study. Apropos of a case in an infant]J A Pincon, P Chatelain, Y Mallet-Guy, et al.
Journal of the American College of Cardiology|April 1, 1987
Improvement of left ventricular contraction and relaxation synchronism after recanalization of chronic total coronary occlusion by angioplastyJ P Melchior, P A Doriot, P Chatelain, et al.
Journal of Cardiovascular Pharmacology|March 1, 1990
Amiodarone pretreatment effects on ischemic isovolumic rat hearts: a P-31 nuclear magnetic resonance study of intracellular pH and high-energy phosphates contents evolutionsL Vander Elst, J F Goudemant, J Mouton, et al.
Diabetologia|October 1, 1988
Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family studyC Thivolet, B Beaufrére, H Bétuel, et al.
Journal of Endocrinological Investigation|February 11, 1999
Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disordersM Bozzola, M Zecca, F Locatelli, et al.
European Journal of Pharmacology|January 14, 1994
31P nuclear magnetic resonance study of the effects of the calcium ion channel antagonist fantofarone on the rat heartL Vander Elst, P Chatelain, A S Manning, et al.
Fundamental & Clinical Pharmacology|January 1, 1992
Treatment with growth hormone-releasing hormone (GHRH) 1-44 in children with idiopathic growth hormone deficiency: a randomized double-blind dose-effect study. The GHRH European Multicenter Study (GEMS) GroupM Lievre, P Chatelain, G Van Vliet, et al.
Diabetes & Metabolism|November 21, 2002
Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large french cohort of family membersC Thivolet, M Nicolino, S Monbeig, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1994
[Immediate results of coronary endoprosthesis in threatening or occlusive dissections complicating angioplasty; the Geneva experience]D Metz, P Urban, B Meier, et al.
FEBS Letters|September 14, 1981
Decreased secretin and glucagon responsiveness of adenylate cyclase in cardiac membranes from hypothyroid ratsP Robberecht, R Pochet, P Chatelain, et al.
Pageof 31

Showing results (231-240 of 306) with videos related to

Sort By:
Pageof 31
Pediatrie|June 1, 1984
[Byler's disease. Ultrastructural study. Apropos of a case in an infant]J A Pincon, P Chatelain, Y Mallet-Guy, et al.
Journal of the American College of Cardiology|April 1, 1987
Improvement of left ventricular contraction and relaxation synchronism after recanalization of chronic total coronary occlusion by angioplastyJ P Melchior, P A Doriot, P Chatelain, et al.
Journal of Cardiovascular Pharmacology|March 1, 1990
Amiodarone pretreatment effects on ischemic isovolumic rat hearts: a P-31 nuclear magnetic resonance study of intracellular pH and high-energy phosphates contents evolutionsL Vander Elst, J F Goudemant, J Mouton, et al.
Diabetologia|October 1, 1988
Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family studyC Thivolet, B Beaufrére, H Bétuel, et al.
Journal of Endocrinological Investigation|February 11, 1999
Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disordersM Bozzola, M Zecca, F Locatelli, et al.
European Journal of Pharmacology|January 14, 1994
31P nuclear magnetic resonance study of the effects of the calcium ion channel antagonist fantofarone on the rat heartL Vander Elst, P Chatelain, A S Manning, et al.
Fundamental & Clinical Pharmacology|January 1, 1992
Treatment with growth hormone-releasing hormone (GHRH) 1-44 in children with idiopathic growth hormone deficiency: a randomized double-blind dose-effect study. The GHRH European Multicenter Study (GEMS) GroupM Lievre, P Chatelain, G Van Vliet, et al.
Diabetes & Metabolism|November 21, 2002
Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large french cohort of family membersC Thivolet, M Nicolino, S Monbeig, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1994
[Immediate results of coronary endoprosthesis in threatening or occlusive dissections complicating angioplasty; the Geneva experience]D Metz, P Urban, B Meier, et al.
FEBS Letters|September 14, 1981
Decreased secretin and glucagon responsiveness of adenylate cyclase in cardiac membranes from hypothyroid ratsP Robberecht, R Pochet, P Chatelain, et al.
Pageof 31